Kate Stringaris

1.3k total citations
19 papers, 575 citations indexed

About

Kate Stringaris is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Kate Stringaris has authored 19 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Kate Stringaris's work include Immune Cell Function and Interaction (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and T-cell and B-cell Immunology (5 papers). Kate Stringaris is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and T-cell and B-cell Immunology (5 papers). Kate Stringaris collaborates with scholars based in United States, United Kingdom and Greece. Kate Stringaris's co-authors include A. John Barrett, Hugues de Lavallade, Jane F. Apperley, Takuya Sekine, Katayoun Rezvani, Katy Rezvani, Jiří Pavlů, Bipin N. Savani, James Davies and Elizabeth J. Shpall and has published in prestigious journals such as Blood, Clinical Cancer Research and Leukemia.

In The Last Decade

Kate Stringaris

17 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Stringaris United States 10 396 238 219 68 58 19 575
Isabel Barão United States 14 586 1.5× 227 1.0× 297 1.4× 90 1.3× 142 2.4× 24 802
James Houston United States 10 461 1.2× 221 0.9× 329 1.5× 69 1.0× 65 1.1× 14 644
Anne Gächter Austria 9 292 0.7× 194 0.8× 287 1.3× 42 0.6× 64 1.1× 13 518
Kyrie Felio United States 7 543 1.4× 234 1.0× 319 1.5× 53 0.8× 107 1.8× 7 766
Stephanie Ku United States 5 395 1.0× 454 1.9× 88 0.4× 96 1.4× 69 1.2× 8 660
Melanie Bremm Germany 14 324 0.8× 246 1.0× 192 0.9× 62 0.9× 43 0.7× 26 473
Lisette van de Corput Netherlands 13 497 1.3× 150 0.6× 169 0.8× 60 0.9× 62 1.1× 19 641
Antoinette Chillemi United States 11 429 1.1× 206 0.9× 358 1.6× 93 1.4× 135 2.3× 12 718
Laura Montiel‐Cervantes Mexico 12 208 0.5× 132 0.6× 243 1.1× 28 0.4× 102 1.8× 35 469
Meghali Goswami United States 13 321 0.8× 198 0.8× 190 0.9× 67 1.0× 249 4.3× 33 692

Countries citing papers authored by Kate Stringaris

Since Specialization
Citations

This map shows the geographic impact of Kate Stringaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Stringaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Stringaris more than expected).

Fields of papers citing papers by Kate Stringaris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Stringaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Stringaris. The network helps show where Kate Stringaris may publish in the future.

Co-authorship network of co-authors of Kate Stringaris

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Stringaris. A scholar is included among the top collaborators of Kate Stringaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Stringaris. Kate Stringaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Marzolini, Maria A. V., Irfan Kayani, Ben Carpenter, et al.. (2024). The Effect of the Pre‐Transplant Disease Status on the Outcome for Recipients of T‐Cell Depleted Allogeneic Haematopoietic Stem Cell Transplants for Large B Cell Lymphomas. European Journal Of Haematology. 114(3). 545–555.
2.
Chaer, Firas El, Uma Borate, Rémy Duléry, et al.. (2021). Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML. Blood Advances. 5(6). 1757–1759. 7 indexed citations
3.
Sato, Noriko, Kate Stringaris, Jan Davidson‐Moncada, et al.. (2020). In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging. Clinical Cancer Research. 26(11). 2573–2581. 51 indexed citations
4.
5.
Stringaris, Kate, Robert F. Hoyt, Jan Davidson‐Moncada, et al.. (2020). Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model. Blood Advances. 4(24). 6148–6156. 7 indexed citations
6.
Allan, David, Mala Chakraborty, Emily R. Levy, et al.. (2017). High-Efficiency Lentiviral Genetic Modification of Primary Human Natural Killer Cells. Blood. 130. 5566–5566. 2 indexed citations
7.
Stringaris, Kate & Austin John Barrett. (2017). The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes. Current Opinion in Hematology. 24(6). 489–495. 20 indexed citations
8.
Alsuliman, Abdullah, Muharrem Müftüoğlu, Ahmad Khoder, et al.. (2016). A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood. 129(6). 740–758. 23 indexed citations
9.
Stringaris, Kate, David Marín, A. John Barrett, et al.. (2016). KIR gene haplotype: an independent predictor of clinical outcome in MDS patients. Blood. 128(24). 2819–2823. 21 indexed citations
10.
Stringaris, Kate, Takuya Sekine, Ahmed Alsuliman, et al.. (2014). Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 99(5). 836–847. 158 indexed citations
11.
Davies, James, Kate Stringaris, A. John Barrett, & Katayoun Rezvani. (2014). Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease. Cytotherapy. 16(11). 1453–1466. 46 indexed citations
12.
Khoder, Ahmad, Abdullah Alsuliman, Takuya Sekine, et al.. (2013). Evidence for Expansion of CD21− B Cells with an Exhausted Phenotype in Patients with Active Chronic GvHD. Biology of Blood and Marrow Transplantation. 19(2). S139–S140. 1 indexed citations
13.
Marín, David, Ian H Gabriel, Sohail Ahmad, et al.. (2011). KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. Leukemia. 26(2). 296–302. 41 indexed citations
14.
Stringaris, Kate, Sharon Adams, Rhoda Eniafe, et al.. (2010). Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 16(9). 1257–1264. 66 indexed citations
15.
Lavallade, Hugues de, Takuya Sekine, Katja Höschler, et al.. (2010). Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica. 96(2). 307–314. 93 indexed citations
16.
Le, Robert Q., Margaret Bevans, Bipin N. Savani, et al.. (2010). Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 16(8). 1162–1170. 24 indexed citations
17.
Lygidakis, N J & Kate Stringaris. (1997). Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.. PubMed. 43(9). 671–80. 4 indexed citations
18.
Nj, Lygidakis, et al.. (1996). Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.. PubMed. 43(7). 212–20. 8 indexed citations
19.
Nj, Lygidakis, et al.. (1992). A new look in the management of unresectable primary hepatocellular carcinoma.. PubMed. 39(6). 577–83. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Barão Breakdown of academic impact, for papers by James Houston Breakdown of academic impact, for papers by Anne Gächter Breakdown of academic impact, for papers by Kyrie Felio Breakdown of academic impact, for papers by Stephanie Ku Breakdown of academic impact, for papers by Melanie Bremm Breakdown of academic impact, for papers by Lisette van de Corput Breakdown of academic impact, for papers by Antoinette Chillemi Breakdown of academic impact, for papers by Laura Montiel‐Cervantes Breakdown of academic impact, for papers by Meghali Goswami
Rankless by CCL
2026